# LUX BIOSCIENCES INC: Form D filings

LUX BIOSCIENCES INC, a biotechnology company in Jersey City, NJ, filed 7 Form D notices with the SEC between 2009 and 2012. The latest, on March 6, 2012, reports $16 million sold of a $17.1 million offering to 8 investors.

Find out what LUX BIOSCIENCES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20LUX%20BIOSCIENCES%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=LUX%20BIOSCIENCES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Flux-biosciences-inc-1366282)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20LUX%20BIOSCIENCES%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=LUX%20BIOSCIENCES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Flux-biosciences-inc-1366282)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: HARBORSIDE FINANCIAL CENTER PLAZA 10, 14TH FLOOR, Jersey City, NJ, 07302
- Phone: (201) 946-0551
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1366282

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 6, 2012 | New notice | $17,110,000 | $16,000,000 | $1,110,000 | 8 | Feb 23, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1366282/000136628212000001/0001366282-12-000001-index.htm) |
| Dec 12, 2011 | New notice | $4,350,000 | $4,000,000 | $350,000 | 10 | Dec 5, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1366282/000136628211000003/0001366282-11-000003-index.htm) |
| Jul 14, 2011 | New notice | $6,000,000 | $6,000,000 | $0 | 10 | Jun 30, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1366282/000136628211000002/0001366282-11-000002-index.htm) |
| Mar 18, 2011 | New notice | $4,500,000 | $3,000,000 | $1,500,000 | 10 | Mar 3, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1366282/000136628211000001/0001366282-11-000001-index.htm) |
| Dec 20, 2010 | New notice | $5,000,000 | $5,000,000 | $0 | 10 | Dec 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1366282/000136628210000001/0001366282-10-000001-index.htm) |
| Oct 30, 2009 | New notice | $49,940,274 | $37,940,274 | $12,000,000 | 10 | Oct 15, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1366282/000136628209000006/0001366282-09-000006-index.htm) |
| Jun 16, 2009 | New notice | $9,200,000 | $9,200,000 | $0 | 10 | Jun 3, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1366282/000136628209000005/0001366282-09-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| David Clarke Schnell | Director |  |
| A. Clarke Atwell | Executive Officer |  |
| Eddy Anglade | Executive Officer |  |
| Lutz Clarke Giebel | Director |  |
| David Clarke Guyer | Director |  |
| Paul Clarke Chaney | Director |  |
| Axel Clarke Bolte | Director |  |
| Thomas Clarke Dyrberg | Director |  |
| Dean Clarke Mitchell | Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Mar 5, 2012](https://specstream.ai/data/form-d/week/2012-03-05) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what LUX BIOSCIENCES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).